Riva-Tenofovir 300 mg

Riva-Tenofovir 300 mg is an oral tablet containing Tenofovir Disoproxil Fumarate, used for managing certain viral infections. This medication is manufactured by Laboratoire Riva Inc. in Canada.

Riva-Tenofovir 300 mg is primarily used for the treatment of chronic hepatitis B and HIV-1 infection. Tenofovir Disoproxil Fumarate, the active ingredient, works by inhibiting the replication of the virus. It is often prescribed as part of a combination therapy to manage these conditions effectively. Patients should consult their healthcare provider to determine if this medication is suitable for their specific needs.

Common effects of Riva-Tenofovir 300 mg may include headaches, nausea, and fatigue. Some users might experience dizziness or mild gastrointestinal discomfort. These effects are generally mild and temporary, but persistent or severe symptoms should be discussed with a healthcare professional.

Riva-Tenofovir 300 mg should be handled with care, especially by individuals with pre-existing kidney conditions. It is important to follow the prescribed dosage and administration instructions provided by a healthcare provider. Regular monitoring of kidney function may be recommended during treatment.

Riva-Tenofovir 300 mg may interact with certain medications, including other antiviral drugs and medications that affect kidney function. Alcohol consumption should be moderated, as it can exacerbate potential side effects. Patients should inform their healthcare provider about all medications they are taking to avoid adverse interactions.